Squamous-cell carcinoma of the anal canal: Predictors of treatment outcome (Diseases of the Colon and Rectum DOI: 10.1007/s10350-007-9125-z);Squamous-cell carcinoma of the anal canal: Predictors of treatment outcome

Diseases of the Colon and Rectum

Volumn 51, Issue 2, 2008, Pages 147-153

  Roohipour, Ramin ^a   Patil, Sujata ^a   Goodman, Karyn A ^a   Minsky, Bruce D ^a   Wong, W Douglas ^a   Guillem, José G ^a   Paty, Philip B ^a   Weiser, Martin R ^a   Neuman, Heather B ^a   Shia, Jinru ^a   Schrag, Deborah ^a   Temple, Larissa K F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Anal canal; Squamous cell carcinoma; Treatment outcomes

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN;

ADULT; ANAL CANAL; ANUS CARCINOMA; ARTICLE; BIOPSY; BIVARIATE ANALYSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTOR VARIABLE; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

EID: 39149086376     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/s10350-008-9216-5     Document Type: Erratum

References (23)

1. Rousseau DL Jr, Thomas CR Jr, Petrelli NJ, Kahlenberg MS. Squamous-cell carcinoma of the anal canal. Surg Oncol 2005;14:121-32.
2. Lopez MJ, Bliss DP Jr, Kraybill WG, Soybel DI. Carcinoma of the anal region. Curr Probl Surg 1989;26:525-600.
3. Beahrs OH, Wilson SM. Carcinoma of the anus. Ann Surg 1976;184:422-8.
4. Boman BM, Moertel CG, O'Connell MJ, et al. Carcinoma of the anal canal. A clinical and pathologic study of 188 cases. Cancer 1984;54:114-25.
5. Johnson LG, Madeleine MM, Newcomer LM, et al. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer 2004;101:281-8.
6. Nigro ND, Vaitkevicius VK, Considine B Jr. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 1974;17:354-6.
7. Bai YK, Cao WL, Gao JD, et al. Surgical salvage therapy of anal cancer. World J Gastroenterol 2004;10:424-6.
8. Meeker WR Jr, Sickle-Santanello BJ, Philpott G, et al. Combined chemotherapy, radiation, and surgery for epithelial cancer of the anal canal. Cancer 1986;57:525-9.
9. Sischy B, Doggett RL, Krall JM, et al. Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314. J Natl Cancer Inst 1989;81:850-6.
10. Enker WE, Heilwell M, Janov AJ, et al. Improved survival in epidermoid carcinoma of the anus in association with preoperative multidisciplinary therapy. Arch Surg 1986;121:1386-90.
11. Cummings BJ, Keane TJ, O'Sullivan B, et al. Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C. Int J Radiat Oncol Biol Phys 1991;21:1115-25.
12. Doci R, Zucali R, La Monica G, et al. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. J Clin Oncol 1996;14:3121-5.
13. Ajani JA, Winter KA, Gunderson LL, et al. Intergroup RTOG 98-11: a phase III randomized study of 5-fluorouracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal. J Clin Oncol 2006;24:3953-8.
14. Akbari RP, Paty PB, Guillem JG, et al. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum 2004;47:1136-44.
15. Renehan AG, Saunders MP, Schofield PF, O'Dwyer ST. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg 2005;92:605-14.
16. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000;342:792-800.
17. Das P, Bhatia S, Eng C, et al. Predictors and patterns of recurrence after definitive chemoradiation for anal cancer. Int J Radiat Oncol Biol Phys 2007;68:794-800.
18. Kim JH, Sarani B, Orkin BA, et al. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. Dis Colon Rectum 2001;44:1496-502.
19. de Bree E, van Ruth S, Dewit LG, Zoetmulder FA. High risk of colostomy with primary radiotherapy for anal cancer. Ann Surg Oncol 2007;14:100-8.
20. Vordermark D, Sailer M, Flentje M, Thiede A, Kölbl O. Curative-intent radiation therapy in anal carcinoma: quality of life and sphincter function. Radiother Oncol 1999;52:329-43.
21. Milano MT, Jani AB, Farrey KJ, et al. Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: toxicity and clinical outcome. Int J Radiat Oncol Biol Phys 2005;63:354-61.
22. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous-cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-9.
23. Höckel M, Knoop C, Schlenger K, et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 1993;26:45-50.